4383-s Urocortin II (Mouse)

Code:
4383-s
Name:
Urocortin II (Mouse)
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2
(M.W. 4152.9) C187H320N56O50
Selective Ligand for Type 2 CRF Receptors
Package Price(Yen)
Vial 0.1 mg 14,000

main

Purity:
≧99.0% (HPLC)
Storage:
-20 ℃

Solubility: H2O (0.1 mM)

more information

Category:
Biologically Active Peptides

reference

  1. T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, and P.E. Sawchenko, Proc. Natl. Acad. Sci. USA, 98, 2843 (2001). (Original)
  2. J.M. Vaughan, C.J. Donaldson, W.H. Fischer, M.H. Perrin, J.E. Rivier, P.E. Sawchenko, and W.W. Vale, Endocrinology, 154, 1553 (2013). (Sequence; Posttranslational Processing)
  3. M. Million, C. Maillot, P. Saunders, J. Rivier,W. Vale, and Y. Taché, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G34 (2002). (Pharmacol.)
  4. C. Li, J. Vaughan, P.E. Sawchenko, and W.W. Vale, J. Neurosci., 22, 991 (2002). (Histochem.)
  5. V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)
  6. C.L. Chang and S.Y.T. Hsu, Peptides, 25, 1681 (2004). (Review)
  7. E.A. Woodcock, Endocrinology, 145, 21 (2004). (Review)
  8. Y. Kuperman and A. Chen, Trends Endocrinol. Metab., 19, 122 (2008). (Review)
  9. W.H. Pan and A.J. Kastin, Prog. Neurobiol., 84, 148 (2008). (Review)
  10. P. Boonprasert, N. Lailerd, and N. Chattipakorn, Int. J. Cardiol., 127, 307 (2008). (Review)